Upcoming Corporate Actions: IGL, Natco Pharma & R Systems
- Share.Market
- 2 min read
- Published at : 30 Sep 2026 12:28 PM
- Modified at : 30 Sep 2026 12:28 PM
Indraprastha Gas Ltd, Natco Pharma Ltd, and R Systems International Ltd, among others, are scheduled to trade ex-date for their respective corporate actions on October 1, 2026. The record date for these corporate actions is also scheduled for October 1, 2026.
Under the T+1 settlement system, transactions take one business day to settle and reflect in a Demat account. Therefore, investors wishing to participate in a corporate action should consider investing before the ex-Date to be eligible.
Indraprastha Gas Ltd.
Indraprastha Gas Ltd (IGL), one of India’s leading city gas distribution companies providing natural gas to domestic, commercial, industrial, and automotive sectors, has declared a Final Dividend of ₹1.5000 per equity share. It has a dividend yield (TTM) of 1.50%
Dividend History
| Ex-Date | Amount (₹) |
| 01 Oct 2026 | 1.50 |
| 18 Feb 2026 | 3.25 |
| 15 Sep 2025 | 1.50 |
| 12 Nov 2024 | 5.50 |
| 13 Sep 2024 | 5.00 |
R Systems International Ltd.
R Systems International Ltd, a global technology and product engineering services provider delivering digital transformation solutions, has declared an Interim Dividend of ₹8.0000 per equity share. It has a dividend yield (TTM) of 2.10%.
Dividend History
| Ex-Date | Amount (₹) |
| 01 Oct 2026 | 8.00 |
| 12 Mar 2026 | 6.00 |
| 14 May 2025 | 6.00 |
| 19 Nov 2024 | 6.50 |
| 28 Mar 2024 | 6.00 |
Natco Pharma Ltd.
Natco Pharma Ltd, a prominent Indian pharmaceutical enterprise specializing in complex generics, active pharmaceutical ingredients (APIs), and niche therapeutic segments, has announced a Right Issue of Equity Shares aggregating up to ₹1,279.36 crore.
Key Details
- Issue Size & Volume: Up to 1,70,58,082 equity shares (face value ₹2 each).
- Issue Price: ₹750 per share (including a premium of ₹748).
- Rights Ratio: 2 Rights Equity Shares for every 21 fully paid-up shares held on the record date.
- Record Date: October 1, 2026.
- Issue Schedule: Opens on October 12, 2026, and closes on October 22, 2026.
- On-Market Renunciation: October 12, 2026, to October 16, 2026.
- RE ISIN: INE987B20018.
The company received in-principle approval from BSE and NSE on September 21, 2026, and approved the Letter of Offer on September 28, 2026. Proceeds will primarily fund debt repayment, R&D, and inorganic expansion.
